MY OVU, a Start-up Med-Tech company founded in 2021, has taken a unique approach to fertility monitoring with a home-based solution for women who wish to conceive or practice natural contraception without hormonal therapy. Recognizing the critical importance of timing, their innovative device—a medical silicone ring equipped with sensors and a computer—collects data throughout the night and transmits it via an app. This device offers significantly more precision than traditional methods by using intravaginal measurements and AI algorithms to accurately identify fertility windows and detect cycle irregularities.
Operating within the burgeoning Femtech Market, MY OVU capitalizes on the increasing global interest in reproductive health and natural family planning. With endorsement from EIT Health via a Support Program investment as of 01 January 2024, the company is well-positioned for scalable growth and international market expansion. Investors may find this opportunity appealing due to the solution's innovative approach and market potential.